Regulatory effects demonstrated for polyphenolic compounds, both flavonoid and non-flavonoid, include prevention from metabolic syndrome, endothelial dysfunctions and cardiovascular diseases due to their antioxidant and anti-inflammatory activity [119], which drew attention to the possible involvement of PON1 in their mechanisms of action. Here, PON1 is linked to metabolic syndrome.